Evaluation of abdominal ultrasonography mass screening for hepatocellular carcinoma in Taiwan

• Published in: Hepatology (Baltimore, Md.) Vol. 59; no. 5; pp. 1840 - 1849
• Main Authors: Yeh, Yen‐Po, Hu, Tsung‐Hui, Cho, Po‐Yuan, Chen, Hsiu‐Hsi, Yen, Amy Ming‐Fang, Chen, Sam Li‐Sheng, Chiu, Sherry Yueh‐Hsia, Fann, Jean Ching‐Yuan, Su, Wei‐Wen, Fang, Yi‐Jen, Chen, Shih‐Tien, San, Hsiao‐Ching, Chen, Hung‐Pin, Liao, Chao‐Sheng
• Format: Journal Article
• Language: English
• Published: United States Wolters Kluwer Health, Inc 01.05.2014; BlackWell Publishing Ltd
• Subjects: Aged; Carcinoma, Hepatocellular - diagnostic imaging; Carcinoma, Hepatocellular - mortality; Confidence intervals; Female; Hepatitis B virus; Hepatobiliary Malignancies; Hepatology; Humans; Liver cancer; Liver Neoplasms - diagnostic imaging; Liver Neoplasms - mortality; Male; Mass Screening - methods; Middle Aged; Mortality; Risk; Taiwan - epidemiology; Ultrasonic imaging; Ultrasonography
• ISSN: 0270-9139; 1527-3350; 1527-3350
• DOI: 10.1002/hep.26703

Mass screening with abdominal ultrasonography (AUS) has been suggested as a tool to control adult hepatocellular carcinoma (HCC) in individuals, but its efficacy in reducing HCC mortality has never been demonstrated. This study aimed to assess the effectiveness of reducing HCC mortality by mass AUS screening for HCC based on a program designed and implemented in the Changhua Community‐based Integrated Screening (CHCIS) program with an efficient invitation scheme guided by the risk score. We invited 11,114 (27.0%) of 41,219 eligible Taiwanese subjects between 45 and 69 years of age who resided in an HCC high‐incidence area to attend a risk score‐guided mass AUS screening between 2008 and 2010. The efficacy of reducing HCC mortality was estimated. Of the 8,962 AUS screening attendees (with an 80.6% attendance rate), a total of 16 confirmed HCC cases were identified through community‐based ultrasonography screening. Among the 16 screen‐detected HCC cases, only two died from HCC, indicating a favorable survival. The cumulative mortality due to HCC (per 100,000) was considerably lower in the invited AUS group (17.26) compared with the uninvited AUS group (42.87) and the historical control group (47.51), yielding age‐ and gender‐adjusted relative mortality rates of 0.69 (95% confidence interval [CI]: 0.56‐0.84) and 0.63 (95% CI: 0.52‐0.77), respectively. Conclusion: The residents invited to community‐based AUS screening for HCC, compared with those who were not invited, showed a reduction in HCC mortality by ∼31% among subjects aged 45‐69 years who had not been included in the nationwide vaccination program against hepatitis B virus infection. (Hepatology 2014;59:1840–1849)